The MRF Applauds FDA’s Commitment to Proposed Tanning Bed Rules

The MRF is proud to join our fellow members of the National Council on Skin Cancer Prevention (NCSCP) in urging the U.S. Food and Drug Administration (FDA) to finalize proposed rules that would ban minors from using tanning beds and require that adult users are better informed about the serious risks of tanning, including potentially fatal skin cancers including melanoma.

The FDA has issued a response to our advocacy efforts, expressly stating that “the proposed rulemaking continues to be a priority for both the Agency and the administration, and it is currently listed as part of the administration’s Unified Agenda with a target date for a final rule in May 2022.” In a follow-up letter this week, the MRF and more than 20 members of the NCSCP applauded the FDA’s commitment to finalizing the rules and ensuring that those in all 50 states are better informed about, and better protected from, the known dangers of tanning beds.

To read the NCSCP letter in full, click here.